[1] MUCKE L.Neuroscience:Alzheimer's disease[J].Nature,2009,461(7266):895-897.
[2] ROSEN Y,LENKINSKI R E.Recent advances in magnetic resonance neuro spectroscopy[J].Neurotherapeutics,2007,4(3):330-345.
[3] SCHUFF N,MEYERHOFF D J,MUELLER S,et al.N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease[J].Adv Exp Med Biol,2006,576(2):24l-263.
[4] BRAND A,RICHTER-LANDSBERG C,LEIBFRITZ D.Multinuclear NMR studies on the energy metabolism of glial and neuronal cells[J].Dev Neurosci,1993,15(3-5):289-298.
[5] 李玉华,张忠阳,殷胜利.正常成人和阿尔茨海默病的扣带回后部质于磁共振频谱研究[J].中国医学影像技术,2006,22(1):64-66.
[6] KANTARCI K,KNOPMAN D S,DICKSON D W,et al,Alzheimer disease:postmortem neuropathologic correlates of antemortem 1H-MR spectroscopy metabolite measurements[J].Radiology,2008,248(1):210-220.
[7] KANTARCI K.Magnetic resonance spectroscopy in common dementias[J].Neuroimaging Clin N Am,2013:23(3):393-406.
[8] KANTARCI K.Proton MRS in mild cognitive impairment[J].J Magn Reson Imaging,2014,37(4):770-777.
[9] KRISHNAN K R,CHARLES H C,DORAISWAMY P M,et al.Randomized,placebo-controlled trial of the effects of donepezil on neutonal markers and hippocampal volumes in Alzheimer's disease[J].Am J Psychiatry,2003,160(11):2003-2011.
[10] KANTARCI K,JACK C R Jr,XU Y C,et al.Regional metabolic paterns in mild cognitive impairment and Alzheimer's disease:a 1H-MRS study[J].Neurology,2000,55(2):210-217.
[11] CARAMANOS Z,NARAYANAN S,ARNOLD D L.1H-MRS quantification of tNA and tCr in patients with multiple sclerosis:a meta-analytic review[J].Brain,2005,128(Pt11):2483-2506.
[12] KANTARCI K,REYNOLDS G,PETEREEN R C,et al.Proton MR spectroscopy in mild cognitive impairment and Alzheimer's disease:comparison of 1.5 T and 3 T[J].AJNR Am J Neuroradiol,2003,24(5):843-849. |